These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 30291957)
21. Epigallocatechin-3-gallate derived polymer coated Prussian blue for synergistic ROS elimination and antibacterial therapy. Zhang Q; Zhang Y; Qi C; Chen J; Hu H; Tan G; Tu J Int J Pharm; 2024 May; 656():124095. PubMed ID: 38588757 [TBL] [Abstract][Full Text] [Related]
22. Potential role of the mitochondria as a target for the hepatotoxic effects of (-)-epigallocatechin-3-gallate in mice. James KD; Kennett MJ; Lambert JD Food Chem Toxicol; 2018 Jan; 111():302-309. PubMed ID: 29175576 [TBL] [Abstract][Full Text] [Related]
23. Molecular identification for epigallocatechin-3-gallate-mediated antioxidant intervention on the H2O2-induced oxidative stress in H9c2 rat cardiomyoblasts. Chen WC; Hsieh SR; Chiu CH; Hsu BD; Liou YM J Biomed Sci; 2014 Jun; 21(1):56. PubMed ID: 24913014 [TBL] [Abstract][Full Text] [Related]
24. Use of leptin-conjugated phosphatidic acid liposomes with resveratrol and epigallocatechin gallate to protect dopaminergic neurons against apoptosis for Parkinson's disease therapy. Kuo YC; Wang IH; Rajesh R Acta Biomater; 2021 Jan; 119():360-374. PubMed ID: 33189953 [TBL] [Abstract][Full Text] [Related]
25. pH-Sensitive Nanoparticles of Epigallocatechin-3-Gallate in Enhanced Colorectal Cancer Therapy. Bhattacharya S; Sangave PC; Belemkar S; Anjum MM Nanomedicine (Lond); 2024 Mar; 19(6):459-481. PubMed ID: 38223987 [TBL] [Abstract][Full Text] [Related]
26. Insight into the structural characteristics of self-assembled liposome with epigallocatechin gallate/alcohol dehydrogenase. Zhang X; Liu L; Jiao X; Su K; Cheng W; Xu B Colloids Surf B Biointerfaces; 2024 Jun; 238():113917. PubMed ID: 38615391 [TBL] [Abstract][Full Text] [Related]
27. Single GUV method reveals interaction of tea catechin (-)-epigallocatechin gallate with lipid membranes. Tamba Y; Ohba S; Kubota M; Yoshioka H; Yoshioka H; Yamazaki M Biophys J; 2007 May; 92(9):3178-94. PubMed ID: 17293394 [TBL] [Abstract][Full Text] [Related]
28. Potent effects of peracetylated (-)-epigallocatechin-3-gallate against hydrogen peroxide-induced damage in human epidermal melanocytes via attenuation of oxidative stress and apoptosis. Ning W; Wang S; Liu D; Fu L; Jin R; Xu A Clin Exp Dermatol; 2016 Aug; 41(6):616-24. PubMed ID: 27339454 [TBL] [Abstract][Full Text] [Related]
29. Protective effect of green tea polyphenol (-)-epigallocatechin gallate and other antioxidants on lipid peroxidation in gerbil brain homogenates. Lee SR; Im KJ; Suh SI; Jung JG Phytother Res; 2003 Mar; 17(3):206-9. PubMed ID: 12672147 [TBL] [Abstract][Full Text] [Related]
30. Antioxidant effects of epigallocatechin-3-gallate on the aTC1-6 pancreatic alpha cell line. Cao T; Zhang X; Yang D; Wang YQ; Qiao ZD; Huang JM; Zhang P Biochem Biophys Res Commun; 2018 Jan; 495(1):693-699. PubMed ID: 29117537 [TBL] [Abstract][Full Text] [Related]
31. Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions. Liang R; Chen L; Yokoyama W; Williams PA; Zhong F J Agric Food Chem; 2016 Dec; 64(48):9180-9188. PubMed ID: 27933988 [TBL] [Abstract][Full Text] [Related]
32. Epigallocatechin-3-gallate protects HUVECs from PM2.5-induced oxidative stress injury by activating critical antioxidant pathways. Yang GZ; Wang ZJ; Bai F; Qin XJ; Cao J; Lv JY; Zhang MS Molecules; 2015 Apr; 20(4):6626-39. PubMed ID: 25875041 [TBL] [Abstract][Full Text] [Related]
33. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies. Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515 [TBL] [Abstract][Full Text] [Related]
34. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation. Frias I; Neves AR; Pinheiro M; Reis S Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184 [TBL] [Abstract][Full Text] [Related]
35. Preservation of (-)-epigallocatechin-3-gallate antioxidant properties loaded in heat treated β-lactoglobulin nanoparticles. Li B; Du W; Jin J; Du Q J Agric Food Chem; 2012 Apr; 60(13):3477-84. PubMed ID: 22409289 [TBL] [Abstract][Full Text] [Related]
36. Interactions of (-)-epigallocatechin-3-gallate with model lipid membranes. Šturm L; Prislan I; González-Ortega R; Mrak P; Snoj T; Anderluh G; Poklar Ulrih N Biochim Biophys Acta Biomembr; 2022 Oct; 1864(10):183999. PubMed ID: 35820494 [TBL] [Abstract][Full Text] [Related]
37. Epigallocatechin gallate inhibits oxidative stress-induced DNA damage and apoptosis in MRL-Fas(lpr) mice with autoimmune sialadenitis via upregulation of heme oxygenase-1 and Bcl-2. Saito K; Mori S; Date F; Ono M Autoimmunity; 2014 Feb; 47(1):13-22. PubMed ID: 24392721 [TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal injection of (-)-Epigallocatechin-3-gallate protects against light-induced photoreceptor degeneration in the mouse retina. Qi S; Wang C; Song D; Song Y; Dunaief JL Mol Vis; 2017; 23():171-178. PubMed ID: 28458506 [TBL] [Abstract][Full Text] [Related]
39. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice. Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847 [TBL] [Abstract][Full Text] [Related]
40. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery. Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]